Journal of Human Hypertension

Journal of Human Hypertension is a monthly clinical journal published by Springer Nature for readers who deal with high blood pressure, founded in 1987.《人类高血压杂志》是一份面向高血压诊疗读者的月刊，由 Springer Nature 出版，创刊于 1987 年。

The title is affiliated with the World Hypertension League and the British and Irish Hypertension Society, and it ranges from epidemiology and pathophysiology to therapeutics and basic work on human subjects or tissues.该刊与世界高血压联盟以及英国与爱尔兰高血压学会保持合作，内容从流行病学、病理生理学延伸到治疗学，以及以人类受试者或组织为基础的基础研究。

In the 2025 edition of the journal citation report it carries an impact factor of 3.3 and stands in the second quartile of peripheral vascular disease.在 2025 年版期刊引证报告中，该刊的影响因子为 3.3，在外周血管病类目中列第二区。

Scope

• The journal is aimed at health care professionals who deal with hypertension, among them specialists, internists and primary care physicians, and at public health workers.该刊面向处理高血压的医疗专业人员，其中包括专科医生、内科医生与全科医生，也面向公共卫生工作者。

• Although the journal is primarily clinical, suitable basic science studies that advance the understanding of human hypertension are also taken.尽管该刊以临床为主，那些增进对人类高血压认识的适当基础研究同样在接纳之列。

• The stated aim is twofold, to increase knowledge in the field of high blood pressure and to improve the standard of care of patients.其宗旨分为两面，一是增进高血压领域的知识，二是提高患者的诊疗水准。

• Papers that deal directly or indirectly with clinical aspects of the disorder are considered, and the range runs from epidemiology and pathophysiology to therapeutics.直接或间接处理该病临床层面的稿件都在考虑之内，范围自流行病学与病理生理学延伸到治疗学。

• Basic science work involving human subjects or tissues is admitted alongside the clinical material.以人类受试者或人体组织为基础的基础研究，与临床材料一并被接纳。

• Submissions from specialties beyond cardiology are welcome, and ophthalmology, nephrology, obstetrics and stroke medicine are named among them.心脏病学之外的专科来稿同样受到欢迎，其中点名提到眼科学、肾脏病学、产科学与卒中医学。

• The complications of high blood pressure, and the various ways in which they present, are treated as part of the subject rather than as a side line.高血压的并发症，以及这些并发症呈现的种种方式，都属于选题的一部分，而非旁支。

• Epidemiology supplies a good share of what the journal prints, and studies of the distribution and determinants of raised pressure in populations are regular fare.流行病学为刊物提供了大部分篇幅，人群中血压升高的分布与决定因素的研究是常见内容。

• Pathophysiology is covered at the level of mechanisms, taking in the vascular and renal processes that underpin the disorder.病理生理学在机制层面得到覆盖，支撑这一疾病的血管与肾脏过程都在其中。

• Therapeutics form a steady strand, with work on drug treatment and on the management of patients across the range of blood pressure elevations.治疗学构成稳定的一支，涵盖药物治疗，以及对各血压升高程度患者的管理。

• The journal also looks at the measurement of blood pressure itself, and at the ways in which readings taken in the clinic, at home and over twenty-four hours are interpreted.该刊还关注血压测量本身，以及诊室血压、家庭血压与二十四小时血压读数各自的解读方式。

• Diet, physical activity and weight management are taken as modifiable factors, and the journal reports trials that test their effect on blood pressure.饮食、身体活动与体重管理被视为可变因素，该刊报道检验其对血压作用的试验。

• The journal covers blood pressure in pregnancy and the hypertensive disorders that complicate it, an area that draws on obstetrics as much as on internal medicine.该刊覆盖妊娠期血压，以及使妊娠复杂化的高血压疾患，这一领域对产科学的依赖不亚于内科。

• Work on secondary hypertension, from endocrine causes to renal disease, is admitted, and the journal follows the diagnostic pathways that separate it from the common form.继发性高血压的工作也被接纳，从内分泌病因到肾脏疾病皆然，该刊还追踪把它与常见类型区分开的诊断路径。

History

• The first issue appeared in 1987, published from Houndmills in Basingstoke by Scientific and Medical, an imprint of Macmillan Press.该刊首期于 1987 年出版，由麦克米伦出版社旗下的 Scientific and Medical 在贝辛斯托克的霍恩米尔斯出版。

• Volume 1 was gathered during 1987, and the numbering has continued without a break since that year.第 1 卷在 1987 年间成册，卷号自那年起一直连续，未曾中断。

• From 2003 the journal has been issued from London by Nature Publishing Group, and that house later became part of Springer Nature.自 2003 年起，该刊由 Nature Publishing Group 在伦敦出版，该机构后来并入 Springer Nature。

• The journal appears twelve times a year, and the monthly rhythm has held for many volumes.该刊每年出版十二期，这一月刊的节奏已延续了许多卷。

• The print number is 0950-9240 and the electronic number is 1476-5527, and the medical catalogue lists the title as J Hum Hypertens.印刷版编号为 0950-9240，电子版编号为 1476-5527，医学目录把该刊记作 J Hum Hypertens。

• The title has been indexed in MEDLINE and PubMed since the first volume, and it also appears in Index Medicus.该刊自第 1 卷起就被 MEDLINE 与 PubMed 收录，也见于 Index Medicus。

• The impact indicator has moved from 3.012 and 2.877 to 2.7 and 3.4, before settling at 3.3 in the 2025 edition.影响因子从 3.012 与 2.877 变为 2.7 与 3.4，并在 2025 年版定格于 3.3。

• A heavy share of what the journal prints is free to read within a year of publication, and the title operates a hybrid open access model.该刊相当一部分内容在出版一年内可免费阅读，刊物实行混合开放获取模式。

• The affiliation with the British and Irish Hypertension Society and the World Hypertension League dates from later years and shapes the clinical community the title serves.与英国及爱尔兰高血压学会、世界高血压联盟的合作始于后来的年份，影响着该刊所服务的临床群体。

• The partnership is described on the journal's own pages, where the two bodies are named as partners rather than as owners.合作关系在刊物自身的页面上有说明，两个机构在那里被列为合作方，而非所有者。

Editors

• The editor-in-chief is Sunil Nadar, a consultant interventional cardiologist at the Dudley Group NHS Foundation Trust in the United Kingdom.主编是（Sunil Nadar），英国 Dudley Group NHS Foundation Trust 的介入心脏病学顾问医师。

• The research interests of the editor lie in platelet activation, hypertension, coronary artery disease and coronary intervention, and the editor is a fellow of the European Society of Cardiology.主编的研究兴趣在于血小板活化、高血压、冠状动脉疾病与冠脉介入，并且是欧洲心脏病学会的会士。

• Eight associate editors share the editorial load, among them Fadi Charchar of Federation University in Australia and Christian Delles of the University of Glasgow.八位副编辑分担编辑工作，其中包括澳大利亚联邦大学的（Fadi Charchar）与格拉斯哥大学的（Christian Delles）。

• The associate editors also take in Catherine Derington of the University of Colorado and Yuichiro Yano of Duke University in the United States.副编辑还包括美国科罗拉多大学的（Catherine Derington）与杜克大学的（Yuichiro Yano）。

• Further associate editors come from Europe and Australia, Federica Piani of the Medical University of Graz, Kalpana Sabapathy of the London School of Hygiene and Tropical Medicine, Pantelis Sarafidis of Aristotle University of Thessaloniki, Manish Sinha of Guy's and St Thomas' in London, Martin Schultz of the University of Tasmania and Jun Yang of the Hudson Institute of Medical Research.其余副编辑来自欧洲与澳大利亚，包括格拉茨医科大学的（Federica Piani）、伦敦卫生与热带医学院的（Kalpana Sabapathy）、塞萨洛尼基亚里士多德大学的（Pantelis Sarafidis）、伦敦盖伊与圣托马斯医院的（Manish Sinha）、塔斯马尼亚大学的（Martin Schultz）与哈德逊医学研究所的（Jun Yang）。

• A representative of the British and Irish Hypertension Society sits with the editors, and Sarah Partridge of the University of Sussex holds that place.英国及爱尔兰高血压学会派出一名代表列席编辑团队，由萨塞克斯大学的（Sarah Partridge）担任。

• The editorial board runs to more than forty names drawn from Britain, the United States, Italy, Japan, China, Brazil and other countries.编委会逾四十人，来自英国、美国、意大利、日本、中国、巴西等国。

• Members work on ambulatory blood pressure monitoring, renal denervation, vascular ageing and the epidemiology of hypertension in low and middle income settings, and several hold positions in national hypertension societies.委员的研究涉及动态血压监测、肾去交感、血管老化，以及中低收入环境下的高血压流行病学，数人还在各国高血压学会任职。

• Manuscripts are submitted through the publisher's online system and are sent to independent referees for peer review.稿件通过出版方的在线系统投递，均送交独立审稿人进行同行评审。

• Metrics published for the title give a median of twenty days from submission to a first editorial decision and a median of one hundred and twenty-nine days from submission to acceptance.该刊公布的指标显示，从投稿到首次编辑决定的中位数为二十天，从投稿到录用的中位数为一百二十九天。